
The Chief Medical Officer along with the Chief Pharmaceutical Officer and the Interim Chief Nursing Officer has writing to provide members with important details regarding the 2025 Spring COVID-19 vaccination programme, which will run from 31st March to 30th June 2025.
The CPS Board is currently discussing and reviewing the following top three items. While these are still "works in progress" and specific details are not yet available, further information will be provided as it becomes available.
We are pleased to confirm that the next Independent Prescribers meeting will take place on Thursday 27th March 2025.
You will have received a form in February, directly from CPS, asking you to send details for your organisation's finance lead and inviting you to join the CPS WhatsApp Groups. If you have not completed and returned the form, you need to do so asap.
As part of the policy team’s involvement on the Digital Prescribing and Dispensing Pathways programme we are looking for your input on some key questions to help inform how the system is built.
The Specialist Pharmacy Services (SPS) website represents a valuable resource to Pharmacy teams and is well worth taking a look at for those not already aware of it.
This week’s MCR Ready Reckoner has been updated and is now available to download or you can view it via the App.
Recent reports have highlighted an increase in sudden collapse after injecting or smoking heroin. This appears linked to a rapid onset into overdose and multiple repeat doses of naloxone being required to reverse overdose.
Our colleagues at the General Pharmaceutical Council (GPhC) will be hosting a virtual event to engage with pharmacy professionals on the key issues shaping the future of pharmacy.
Community Pharmacy Scotland (CPS) is delighted to host its 11th Annual Charity Golf Day at the stunning Mar Hall Golf and Spa Resort. To help raise essential funds for this remarkable charity, we have expanded our sponsorship opportunities, allowing more businesses to contribute and gain valuable exposure.
Community Pharmacy Scotland (CPS) attended the annual Pharmacy in Practice Conference on the 12th March 2025 in Edinburgh. The day consisted of a breadth of panel discussion sessions focusing on innovation in, and the future of pharmacy practice.
Your next courier collection is scheduled for Thursday, March 20th, 2025. We have produced the following guidelines for your prescription bag submissions.
The Detect Cancer Earlier campaign ‘Be the Early Bird’ is LIVE throughout March 2025 but with a difference! A new Early Bird, ‘Bonnie’, has been introduced to raise awareness of lesser known head and neck cancer symptoms. We are delighted to share NEW campaign material and would welcome your support in helping us spread this important #BeTheEarlyBird message once again.
Endometriosis Awareness Month is taking place throughout March and is dedicated to raising awareness about endometriosis, a chronic and painful condition affecting many women across the UK. This month provides an opportunity to increase public understanding of the condition and encourage those who are suffering to seek medical advice from their GP practice.
From 1st April 2025, it will be a legal requirement for individuals to be a member of the PVG Scheme when carrying out a regulated role with children, protected adults, or both.
There have been some clinical incidents as a result of higher than expected levels of Vit D3 being in the product.
Pharmacies across Scotland have the opportunity to contribute to the development of the future pharmacy workforce by supporting student pharmacist experiential learning (EL) in the 2025-26 academic year.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol for Estradot® (Estradiol) 50 micrograms / 24 hours transdermal patch, a hormone replacement therapy product has been extended.
We are pleased to see that the House of Lords recently held a debate which used community pharmacy as a central talking point, eventually voting overwhelmingly in favour of granting an exemption to this rise in business costs.
The approved list of products for the NHS Pharmacy First Scotland Service has been updated from the 1st March 2025.
Due to the day on which the 1st March falls this year, we will publish the March edition of Part 7 on the website slightly later than usual, early next week.
We are pleased to let you know that there are two new Teach and Treat Hubs coming in April. The new hubs will be in Saracen Pharmacy and Garscadden Pharmacy, and will support the delivery of the Teach & Treat sessions.
Congratulations to everyone who has recently passed their Independent Prescribing Courses. Well done! Once you have had the chance to celebrate, here are some details for next steps.
As part of the preparations for the recruitment process for the summer 2026 intake of Foundation Training Year (FTY) trainee pharmacists,
Your next courier collection is scheduled for Thursday, March 6th, 2025. We have produced the following guidelines for your prescription bag submissions.
From 4th November 2024, the Ask for ANI scheme has no longer been available in pharmacies. However, the Safe Spaces scheme has continued in over 6,000 Pharmacies, Banks and Building Societies across the UK. The Safe Spaces scheme is overseen by Scottish Women’s Aid/Hestia.
Do you have questions about NHS Pharmacy First Scotland / NHS PFS Plus and or the UCF Module?
New resources have been developed to support healthcare professionals in the management of Valproate prescribing.
Our Community Pharmacy Health Board (CPHB) committees are at the forefront of local service negotiation. Currently, a number of our CPHB Committees have vacancies available for Associate Members for the term 2025-2028.
Vicky Park, a Senior Educator with NES Pharmacy, is currently looking for participants for an MSc research project on the remote assessment of physical assessment skills, which may support our understanding of assessment options going forward.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol for Estradot® (Estradiol) 50 micrograms / 24 hours transdermal patch, a hormone replacement therapy product has been extended.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol (SSP) for cefalexin 125mg / 5ml oral suspension sugar free due to expire on 31 January 2025 has been extended until Friday 2 May 2025.
Serious Shortage Protocols (SSP) in place for cefalexin 125mg / 5ml & 250mg / 5ml oral suspension sugar free, from 10 December 2024 to 31 January 2025.
Serious Shortage Protocols (SSPs) are now in place for Estradot® (estradiol) 50 mcg, 75 mcg & 100 mcg / 24 hour transdermal patch, from 19 December 2024 to 28 January 2025.
This Circular informs NHS Boards and community pharmacy contractors of the intention to continue funding for Community Pharmacist Practitioner Champions in 2024-25.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol (SSP) for Ramipril 2.5mg tablets due to expire on 15 November 2024 has been extended until Friday 29 November 2024.
This Circular advises community pharmacy contractors of a new Universal Claim Framework (UCF) module that will be available for use by providers of Pharmacy First Plus from 1 February 2025.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol for isosorbide mononitrate (Monomax® XL) 60mg modified release tablet due to expire on 18 October 2024 has been extended until Friday 15 November 2024.
This Circular advises community pharmacy contractors of an updated Patient Group Direction (PGD) that is to be implemented for the provision of desogestrel as bridging contraception.
This Circular advises community pharmacy contractors of changes to NHS prescription stationery for the CP4/3 prescription form.
This circular sets out to community pharmacy contractors the details of the community pharmacy funding arrangement for 2024/25.
To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Chemydur® 60XL) modified release tablet, from 6 September 2024 to 27 September 2024.
This Circular advises contractors of a balancing payment relating to the 2023/24 global sum, which will be made along with September’s payments.
To advise of a Serious Shortage Protocol (SSP) in place for cefalexin 500mg tablets, from 6 August 2024 to 27 September 2024.
To advise of a Serious Shortage Protocol (SSP) in place for ramipril 2.5mg tablets, from 6 August 2024 to 15 November 2024.
The Scottish Government have released Circulars PCA(2024)12 through to 20 advising of Serious Shortage Protocols (SSPs) that are in place in relation to supply issues with Quetiapine 150mg, 200mg and 300mg tablets.
This Circular advises community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic products due to expire on 21 June 2024 have now been extended until Friday 19 July 2024.
This Circular advises Health Boards and community pharmacy contractors that a series of Public Health Service (PHS) poster campaigns is planned to be distributed to pharmacies over the course of 2024/25
This Circular advises Health Boards and community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml and 250mg/5ml oral suspension have been reactivated on 22 May 2024. The new end date for both SSPs is now 21 June 2024.
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 25000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 10000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
This circular advises community pharmacy contractors and NHS Boards on the amendments to the Drug Tariff Part 11 clawback scale.
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet due to expire on 3 May 2024 has been extended until Friday 31 May 2024.
This Circular encloses new guidance for dispensing General Practises across Scotland.
To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet, from 26 March 2024 to 3 May 2024.
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of shingles and skin infections under NHS Pharmacy First Scotland.
This Circular advises NHS Boards and healthcare professionals that print copies of the British National Formulary (BNF) and BNF for Children (BNFC) will no longer be provided
PCA(P)(2023)46 - Pharmaceutical Services Amendments To The Drug Tariff Part 11 Discount Clawback Scale
This Circular provides updated guidance aimed at both community optometry and community pharmacy teams and an updated referral form for the assessment and treatment of minor eye conditions.
This circular advises community pharmacy contractors and Health Boards of a corrective payment in order to deliver contractual requirements for the financial year 2023/24.

The approved list of products for the NHS Pharmacy First Scotland Service has been updated from the 1st March 2025.
Do you have questions about NHS Pharmacy First Scotland / NHS PFS Plus and or the UCF Module?
First Minister John Swinney addressed the nation yesterday (27/01/25) to outline plans for NHS reform, pledging to reduce waiting lists, enhance the NHS Pharmacy First Scotland service.
Our Policy and PR Pharmacist attended the Norsk Farmasoytisk Selskap Pharmacy Conference in Oslo last Thursday where she gave a presentation on NHS Pharmacy First Scotland.
There has been an update to the NHS Pharmacy First Scotland Approved List.
Community Pharmacy Scotland has been made aware of confusion around some of the NHS Pharmacy First Scotland service (PFS) Urinary Tract Infection (UTI) Patient Group Direction (PGD) details. We thought it would be useful to clarify these points.
Our colleagues at Scottish Government have produced an NHS Pharmacy First Scotland Service Communications Toolkit to help promote Pharmacy First services in Scotland. There are two kits available: one specifically for women's health services and one for general services.
There has been an update to the respiratory section of the NHS Pharmacy First (Scotland) Service Approved List of Products. This means that there are no longer any products listed under cough. It was agreed to remove Simple linctus sugar free, all pack sizes.
There has been an update to the NHS Pharmacy First Scotland Approved List.
guidance for the NHS Pharmacy First Scotland (NHS PFS) service, which is in response to previous questions and outcomes from live events held with the community pharmacy network.
Referrals into community pharmacy from other healthcare professionals are becoming more frequent as community pharmacy services become more well known. This may result in an increase in recommendations to patients from other healthcare professionals when referring them to the community pharmacy for care.
The Scottish Government have updated the NHS Pharmacy First Approved List and to follow national prescribing guidance Simple Linctus sugar-free and Simple Linctus Paediatric sugar-free have now been removed from this list.
The update is to Section 10 Skin to remove Epimax Ointment and Epimax Paraffin free Ointment from NHS Grampian’s list only.
The NHS Pharmacy First Scotland Service approved list of products has been updated as of 1st of April 2024.
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of shingles and skin infections under NHS Pharmacy First Scotland.
We have been working with Scottish Government and NHS colleagues on trying to capture Pharmacy First Plus prescribing, advice and referrals data to better evidence the great work being done out in the network – at the moment, this cannot be separated out from standard Pharmacy First activity.
As some of you may be aware, NHS England are due to launch the NHS Pharmacy First service in English community pharmacies on 31st of January 2024.
Each local NHS Health Board has the ability to develop bespoke local pharmacy services to suit the needs of local communities and patients
This Circular provides updated guidance aimed at both community optometry and community pharmacy teams and an updated referral form for the assessment and treatment of minor eye conditions.
Patient Group Directions (PGDs) that are to be added to the NHS Pharmacy First Scotland service for the treatment of seasonal allergic rhinitis (hay fever).
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of urinary tract infections (UTI) and impetigo under NHS Pharmacy First Scotland.
As part of a move to a regional formulary review process in the East of Scotland, both NHS Lothian and NHS Borders will very shortly inform contractors that the dose of Flucloxacillin permitted
Our colleagues in Primary Care have highlighted the attached website as a source of information for professionals and patients which you may find useful in your practice, and Pharmacy First and First Plus in particular.
Circular PCA(P)(2021)5 set out the arrangements for the settlement for pharmaceutical services for the period 2020-21, including for NHS Pharmacy First Scotland.
Since its launch in the midst of the pandemic, you and your teams have supported the people of Scotland with their minor health conditions over 2 million times!
With the Revised List of Approved List Products (PCA (P) (2021) 14) Circular, from 1st October 2021
This Circular encloses a revised Approved List of Products for the NHS Pharmacy First Scotland service, which will come into force from 1st October 2021.
Circular PCA(P)(2021)07 advises that Patient Group Directions (PGDs) supporting two further common clinical conditions will be added to the NHS Pharmacy First Scotland service.
This Circular provides information for community optometry teams about the NHS Pharmacy First Scotland (NHS PFS) service. It also provides guidance aimed at both community optometry and community pharmacy teams and a referral form for the assessment and treatment of minor eye conditions.
This circular informs NHS Boards and community pharmacy contractors of the intention to establish a combined National Foundation Programme and Independent Prescriber (IP) Career Pathway for community pharmacists.
The approved list of products for the NHS Pharmacy First Scotland Service has been updated from the 1st March 2025.